WEST PHARMACEUTICAL SERVICES, INC. Total Long-Term Debt
WEST PHARMACEUTICAL SERVICES, INC. (WST) had Total Long-Term Debt of $202.90 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Liabilities › Debt
us-gaap:LongTermDebt · last filed 2026-07-23
- 2026-06-30: Long-term Debt $202.90M.
- 2026-03-31: Long-term Debt $202.80M.
- 2025-12-31: Long-term Debt $202.80M.
- 2025-09-30: Long-term Debt $202.70M.
| Period end | Long-term Debt | Long-term Debt as first filed |
|---|---|---|
| 2026-06-30 | $202.90M 10-Q · filed 2026-07-23 | |
| 2026-03-31 | $202.80M 10-Q · filed 2026-04-23 | |
| 2025-12-31 | $202.80M 10-Q · filed 2026-07-23 | |
| 2025-09-30 | $202.70M 10-Q · filed 2025-10-23 | |
| 2025-06-30 | $202.60M 10-Q · filed 2025-07-24 | |
| 2025-03-31 | $202.60M 10-Q · filed 2025-04-24 | |
| 2024-12-31 | $202.60M 10-K · filed 2026-02-17 | |
| 2024-09-30 | $202.60M 10-Q · filed 2024-10-24 | |
| 2024-06-30 | $205.80M 10-Q · filed 2024-07-25 | |
| 2024-03-31 | $206.20M 10-Q · filed 2024-04-25 | |
| 2023-12-31 | $206.80M 10-K · filed 2025-02-18 | |
| 2023-09-30 | $207.30M 10-Q · filed 2023-10-26 | |
| 2023-06-30 | $207.80M 10-Q · filed 2023-07-27 | |
| 2023-03-31 | $208.30M 10-Q · filed 2023-04-27 | |
| 2022-12-31 | $208.90M 10-K · filed 2024-02-20 | |
| 2022-09-30 | $209.40M 10-Q · filed 2022-10-27 | |
| 2022-06-30 | $252.00M 10-Q · filed 2022-07-28 | |
| 2022-03-31 | $252.50M 10-Q · filed 2022-04-28 | |
| 2021-12-31 | $253.00M 10-K · filed 2023-02-21 | |
| 2021-09-30 | $254.10M 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $254.10M 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $254.60M 10-Q · filed 2021-04-30 | |
| 2020-12-31 | $255.20M 10-K · filed 2022-02-22 | |
| 2020-09-30 | $255.70M 10-Q · filed 2020-10-23 | |
| 2020-06-30 | $256.20M 10-Q · filed 2020-07-24 | |
| 2020-03-31 | $256.70M 10-Q · filed 2020-04-24 | |
| 2019-12-31 | $257.30M 10-K · filed 2021-02-23 | |
| 2019-09-30 | $195.10M 10-Q · filed 2019-10-29 | |
| 2019-06-30 | $196.00M 10-Q · filed 2019-07-29 | |
| 2019-03-31 | $195.50M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $196.10M 10-Q · filed 2019-10-29 | |
| 2018-09-30 | $196.20M 10-Q · filed 2018-10-30 | |
| 2018-06-30 | $196.40M 10-Q · filed 2018-07-31 | |
| 2017-12-31 | $197.00M 10-K · filed 2019-02-28 | |
| 2016-12-31 | $228.60M 10-K · filed 2018-02-26 | |
| 2015-12-31 | $298.20M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $302.50M 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $326.70M 10-Q · filed 2015-08-03 | |
| 2015-03-31 | $330.70M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $335.50M 10-K · filed 2016-02-26 | $336.70M 10-K · filed 2015-02-25 |
| 2014-09-30 | $342.70M 10-Q · filed 2014-11-03 | |
| 2014-06-30 | $361.50M 10-Q · filed 2014-08-01 | |
| 2014-03-31 | $404.90M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $373.50M 10-K · filed 2015-02-25 | |
| 2013-09-30 | $400.00M 10-Q · filed 2013-11-04 | |
| 2013-06-30 | $394.80M 10-Q · filed 2013-08-05 | |
| 2013-03-31 | $430.10M 10-Q · filed 2013-05-06 | |
| 2012-12-31 | $411.50M 10-K · filed 2014-02-27 | |
| 2012-09-30 | $401.40M 10-Q · filed 2012-11-05 | |
| 2012-06-30 | $385.50M 10-Q · filed 2012-08-06 | |
| 2012-03-31 | $289.50M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $349.40M 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |